Mo1111 RNASET2 RISK VARIANT AS A NOVEL BLOOD BASED...

Gastroenterology 2020 / 05 Vol. 158; Iss. 6

Mo1111 RNASET2 RISK VARIANT AS A NOVEL BLOOD BASED DIAGNOSTIC FOR DEFINING A SEVERE CD PATIENT POPULATION RESPONSIVE TO DIRECTED RNASET2 THERAPEUTICS

Gonsky, Rivkah, Biener-Ramanujan, Eva, Printsev, Ignat., Kim, Frank, McGovern, Dermot P.B., Bilsborough, Janine, Targan, Stephan R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)32652-4
Date:
May, 2020
File:
PDF, 129 KB
2020
Conversion to is in progress
Conversion to is failed